Pharma giant AstraZeneca on Saturday said that clinical trials for the
AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the
UK following confirmation by the Medicines Health Regulatory Authority
(MHRA) that the trials were safe.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/will-resume-covid-19-vaccine-trials-after-dcgi-nod-serum-institute/articleshow/78081119.cms
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment